The risk of upper gastrointestinal bleeding associated with concomitant proton pump inhibitor administration during dual antiplatelet therapy with aspirin and prasugrel: a retrospective single-center study

The risk of upper gastrointestinal bleeding associated with concomitant proton pump inhibitor administration during dual antiplatelet therapy with aspirin and prasugrel: a retrospective single-center study

Abstract Objective Dual‐antiplatelet therapy (DAPT) and proton pump inhibitor (PPI) are frequently prescribed after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) placement. However, studies that evaluate the optimal PPI when used as primary prevention in patients without a...

Full description

Saved in:
Bibliographic Details
Main Authors: Yutaro Ide, Go Morikawa, Kyohei Yoshida, Yuki Takano, Ken Kubota, Katsuko Okazawa, Takeo Yasu
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Journal of Pharmaceutical Health Care and Sciences
Subjects:
PCI
DAPT
PPI
UGBI
Prasugrel
Lansoprazole
Online Access:https://doi.org/10.1186/s40780-024-00398-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items